Since routine CRP quantification methods are gradually replaced by automated hs-CRP methods,[41] further studies to determine an optimal hs-CRP cut-off value for outcome prediction in HCC are warranted. This evidence concerns the gene MAP3K14 and hepatocellular carcinoma.